We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Nxstage Medical, Inc. | NASDAQ:NXTM | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 30.00 | 29.99 | 30.00 | 0 | 01:00:00 |
From Jun 2019 to Jun 2024
By Donato Paolo Mancini
Fresenius Medical Care AG & Co. KGaA (FME.XE) and NxStage Medical Inc. (NXTM) have extended their merger agreement end date due to the U.S. government shutdown, Fresenius said Tuesday.
The move is to account for the interruption of the Federal Trade Commission's review of the transaction during the recent shutdown.
The merger date has been moved to Aug. 6, 2019, or to an earlier date for which the FTC will have been fully funded for 60 consecutive days, Germany's Fresenius said.
Write to Donato Paolo Mancini at donatopaolo.mancini@dowjones.com; @donatopmancini
(END) Dow Jones Newswires
January 29, 2019 08:31 ET (13:31 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
1 Year Nxstage Medical Chart |
1 Month Nxstage Medical Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
